(Q46216843)

20 December 2017

title

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial (English)

1 reference

20 December 2017

0 references

0 references

3

Elizabeth M Brunt

1 reference

20 December 2017

author name string

Stephen A Harrison

series ordinal

1

1 reference

20 December 2017

Will Fecht

series ordinal

2

1 reference

20 December 2017

Brent A Neuschwander-Tetri

series ordinal

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

20 December 2017

published in

Hepatology

1 reference

20 December 2017

volume

49

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

80-86

1 reference

20 December 2017

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

cites work

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Benefits of lifestyle modification in NAFLD.

21 January 2018

1 reference

A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients

21 January 2018

1 reference

Orlistat in the treatment of NASH: a case series

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects

21 January 2018

1 reference

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

21 January 2018

1 reference

Effect of weight reduction on hepatic abnormalities in overweight patients

21 January 2018

1 reference

Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review

21 January 2018

1 reference

Orlistat and sibutramine beyond weight loss

21 January 2018

1 reference

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

21 January 2018

1 reference

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis

21 January 2018

1 reference

Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus

21 January 2018

1 reference

Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women

1 reference

7 January 2021

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years

1 reference

7 January 2021

Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22575

1 reference

20 December 2017

PubMed ID

19053049

1 reference

20 December 2017